Zinc Patents (Class 424/641)
For topical application (Class 424/642)
Orally assimilable or injectable composition (Class 424/643)
  • Biodegradable, non-toxic biological adhesive for use in abdominal surgery
    Patent number: 8252333
    Abstract: A biological adhesive formulation comprising dextrin, at least one adhesiveness modifier agent, and at least one antibiotic is suitable for promoting healing of tissue in a patient, for example, to prevent anastomosis of a surgical wound in the digestive system of a patient, and for affixing a prosthesis during a hernia operation.
    Type: Grant
    Filed: August 22, 2006
    Date of Patent: August 28, 2012
    Inventor: Jorge Cueto-Garcia
  • Method and system for effecting changes in pigmented tissue
    Publication number: 20120207809
    Abstract: Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease.
    Type: Application
    Filed: November 30, 2011
    Publication date: August 16, 2012
    Inventor: Kambiz Thomas Moazed
  • Methods and compositions for heavy metal detoxification
    Patent number: 8241674
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: August 14, 2012
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • ANTIVIRAL MATERIAL , ANTIVIRAL FILM, ANTIVIRAL FIBER, AND ANTIVIRAL PRODUCT
    Publication number: 20120201861
    Abstract: In one embodiment, an antiviral material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide composite microparticles. The microparticles have an inactivation effect R of 1 or more expressed by [R=logC?logA], when there is evaluated a virus titer by inoculating on a specimen to which the microparticles are adhered, at least one virus selected from a low pathogenic avian influenza virus (H9N2), a high pathogenic avian influenza virus (H5N1) and a swine influenza virus, and irradiating the specimen with visible light having a wavelength of 380 nm or more and illuminance of 6000 1× for 24 hours.
    Type: Application
    Filed: February 9, 2012
    Publication date: August 9, 2012
    Inventors: Kayo NAKANO, Akira Sato, Takao Kusaka, Shinya Kasamatsu, Akito Sasaki, Daisuke Fukushi
  • METHODS FOR MAKING EMBRYONIC CELLS, EMBRYOS, AND ANIMALS SENSITIZED TO STRESS
    Publication number: 20120198576
    Abstract: Embodiments of the invention are based upon the discovery that exposure of cleavage-stage embryos to a stress inducer, e.g. heat shock or chemical, renders the exposed embryos more sensitive to a secondary treatment with a stress inducer, e.g. heat shock or chemical inducer. Accordingly, the present invention is directed to methods for making embryos, embryonic cells arising from them, and animals and plants that are sensitized to stress, e.g. physiologic or chemical stressors. Methods of screening for inducers and inhibitors of stress using, as test model systems, embryonic cells, embryos, animals, and plants that are sensitized to stress are also disclosed.
    Type: Application
    Filed: July 1, 2010
    Publication date: August 2, 2012
    Applicant: BRANDEIS UNIVERSITY
    Inventors: Lawrence J. Wangh, Cristina Hartshorn, Yanwei Jia
  • Nutritional Composition for Equine Reproductive Health
    Publication number: 20120197067
    Abstract: An equine nutritional composition comprising: i) a first component comprising micronutrients, wherein said micronutrients include: the amino acids L-carnitine, L-arginine, L-cysteine and, optionally, L-lysine; folate; and, at least one mineral element selected from the group consisting of: selenium, iron, calcium, magnesium, copper, zinc and manganese; and, ii) a second component comprising one or more fatty acids selected from each of the groups: omega-3 fatty acids; and, omega-6 fatty acids. The equine nutritional composition has utility in improving aspects of the reproductive health of stallions.
    Type: Application
    Filed: January 30, 2012
    Publication date: August 2, 2012
    Applicant: PRIMEVAL B.V.
    Inventors: Dirk Evert KAT, Ira Mirella DRESCH
  • METHODS OF ATTENUATING THE LOSS OF FUNCTIONAL STATUS
    Publication number: 20120195873
    Abstract: Nutritional compositions and methods of using the nutritional compositions with exercise to attenuate the loss of functional status are provided. In a general embodiment, the present disclosure provides a nutritional composition including whey protein, and Vitamin D. The nutritional composition and exercise can be specifically used to attenuate the loss of functional status, especially in the elderly.
    Type: Application
    Filed: July 15, 2010
    Publication date: August 2, 2012
    Applicant: NESTEC S.A.
    Inventors: Kevin Burke Miller, Ingo Arne Jurk, Zamzam Kabiry Roughead
  • HYDROGEL BIOSCAFFOLD AND COATING FOR BONE AND TOOTH REPAIR
    Publication number: 20120189668
    Abstract: Hydrogel compositions that include an albumin/N-acetyl cysteine solution and an aqueous suspension of calcium salts or mixture of calcium and magnesium salts are described. Also described are methods of producing and using the hydrogel compositions as a support scaffold for mineralizing connective tissue replacement and repair.
    Type: Application
    Filed: January 26, 2012
    Publication date: July 26, 2012
    Inventor: Stanley William Whitson
  • METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE TO TREAT A CONDITION
    Publication number: 20120189709
    Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.
    Type: Application
    Filed: January 11, 2012
    Publication date: July 26, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Debra L. Thomas, Pradip Mukerji
  • COMPOSITIONS FOR THE TREATMENT OF HEMORRHOIDS AND RELATED DISEASES
    Publication number: 20120183627
    Abstract: The present invention relates to pharmaceutical, nutraceutical, health foods and medical device compositions comprising polysaccharides from Opuntia Ficus Indica cladodes in combination with antioxidant and anti-inflammatory plant extracts as well as those from Olive leaf, Capparis Spinosa buttons, anthocianosides from red oranges, black rice or from other natural sources and their combinations, useful for prevention and therapy of hemorrhoidal disease and related diseases. The invention compositions may, be applied topically or administered by oral route.
    Type: Application
    Filed: September 1, 2010
    Publication date: July 19, 2012
    Applicant: BIONAP SRL.
    Inventors: Luisa Rizza, Salvatore Munafo, Alberto Serraino
  • Nitric oxide delivery system
    Patent number: 8221800
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: July 17, 2012
    Assignee: Geno LLC
    Inventors: David H. Fine, Stephen J. MacDonald, David R. Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR THE TREATMENT OF CANCER
    Publication number: 20120177744
    Abstract: Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, including an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disclosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.
    Type: Application
    Filed: January 11, 2012
    Publication date: July 12, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Debra L. Thomas, Pradip Mukerji
  • Compositions and Methods for Treating Lameness in Hoofed Domesticated Animals Due to Hairy Foot Warts and Foot Rot
    Publication number: 20120177747
    Abstract: Compositions and methods for preventing or controlling lameness in domesticated hoofed animals due to hairy foot warts and foot rot comprising a biocidal system comprised of a primary biocide and a secondary biocide; a pH buffer agent; a surfactant; all in an aqueous based carrier.
    Type: Application
    Filed: January 9, 2012
    Publication date: July 12, 2012
    Applicant: NOBLE ION, LLC
    Inventors: Burt R. Sookram, John W. Veenstra
  • Mitigation of Animal and Plant Diseases Using Bioavailable Minerals
    Publication number: 20120171130
    Abstract: A composition is able to treat plant and animal diseases and includes a therapeutically effective amount of an encapsulated ionic mineral complex and a pharmaceutically acceptable carrier. The composition may also include other inert ingredients, botanical extracts and vitamin and mineral supplements.
    Type: Application
    Filed: October 31, 2007
    Publication date: July 5, 2012
    Inventor: John Wayne Kennedy
  • Compositions containing zinc salts for coating medical articles
    Patent number: 8207148
    Abstract: The present invention relates to methods and compositions which employ low concentrations of combinations of zinc salts and antimicrobial agents in coatings for medical articles. The coatings have an anti-irritant effect and inhibit transmission of infectious disease.
    Type: Grant
    Filed: March 1, 2010
    Date of Patent: June 26, 2012
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Shanta M. Modak, Lauserpina Caraos
  • Nutritional supplement for use under physiologically stressful conditions
    Patent number: 8202546
    Abstract: In one embodiment of the present invention, a pharmaceutically-acceptable single-dosage formulation consists essentially of about 300 mg of vitamin C; about 1200 IUs of vitamin D3; about 125 IUs of vitamin E; about 25 mg of vitamin B1; about 3.4 mg of vitamin B2; about 35 mg of niacin; about 35 mg of vitamin B6; about 1.25 mg of folate; about 70 mcg of vitamin B12; about 5 mg of pantothenic acid; about 300 mcg of biotin; about 50 mg of calcium; about 35 mg of magnesium; about 35 mg of zinc; about 1 mg of copper; about 125 mcg of selenium; about 150 mcg of chromium; about 25 mg of alpha lipoic acid; about 35 mg of co-enzyme Q-10; about 2 mg of lutein; about 500 mcg of lycopene; about 5 mg of pepper extract; and at least one or more excipients.
    Type: Grant
    Filed: February 2, 2010
    Date of Patent: June 19, 2012
    Assignee: Vertical Pharmaceuticals, Inc.
    Inventors: Steven A. Squashic, Kevin M. Hudy, David C. Purdy
  • MULCH-MODIFYING SPRAYABLE LATEX
    Publication number: 20120148650
    Abstract: This disclosure concerns improved mulch holding, mulch preserving, and/or mulch pigmenting sprayable latex, and its application to preserving the appearance of decorative mulch, either by fixing decorative mulch in place more effectively than prior mulch-holding latex, by protecting the mulch from biological or UV degradation, by pigmenting or staining the mulch, or some combination of two or more of these characteristics.
    Type: Application
    Filed: August 19, 2011
    Publication date: June 14, 2012
    Inventors: Michael R. Hogatt, Roger W. Faulkner, James L. Zwynenberg
  • Articles Having Antimicrobial Properties And Methods of Manufacturing the Same
    Publication number: 20120148651
    Abstract: According to one embodiment, a coagulant comprising calcium nitrate and an antimicrobial agent is disclosed. The coagulant may be used in the molding process to releasably bond the substrate material to the mold and to bond to the antimicrobial to the substrate material.
    Type: Application
    Filed: December 10, 2010
    Publication date: June 14, 2012
    Applicant: MEDLINE INDUSTRIES INC.
    Inventors: Samuel T. Amdur, Min Yao
  • BINARY AND TERTIARY GALVANIC PARTICULATES AND METHODS OF MANUFACTURING AND USE THEREOF
    Publication number: 20120148633
    Abstract: The present invention relates to galvanic particulates, their methods of manufacture and uses in treatments are described. The galvanic particulates may be binary or tertiary galvanic particulates, for example, containing multiple layers or phases of conductive materials.
    Type: Application
    Filed: March 25, 2010
    Publication date: June 14, 2012
    Inventors: Ying Sun, Jue-Chen Liu, Michael Southall, Luiz Arthur Bonaci Tessarotto, Leon B. Kriksunov
  • Compositions and methods for nutrition supplementation
    Patent number: 8197855
    Abstract: The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: June 12, 2012
    Assignee: Everett Laboratories, Inc.
    Inventors: John A. Giordano, Charles J. Balzer
  • Nutritional supplement for use under physiologically stressful conditions
    Patent number: 8197854
    Abstract: A nutritional supplement for use in physiologically stressful conditions is disclosed. The nutritional supplement may include one or more of vitamin A, vitamin E, vitamin D3, vitamin C, vitamin B1, riboflavin, niacin, folic acid, vitamin B6, biotin, pantothenic acid, vitamin B12, magnesium, zinc, selenium, chromium, copper, iron, alpha lipoic acid, lutein and lycopene.
    Type: Grant
    Filed: March 7, 2011
    Date of Patent: June 12, 2012
    Assignee: Vertical Pharmaceuticals, Inc.
    Inventors: Steven A. Squashic, Kevin M Hudy, David C. Purdy
  • Regulation Of Bone Growth Using Zeolite In Combination With Bone Graft Substitutes
    Publication number: 20120141599
    Abstract: Medical implants such as bone graft substitutes that include one or more cations are delivered in a local environment to promote osteogenesis. Zeolite loaded with a metal cation in combination with an implant such as a bone graft substitute can be used as an implant in the body to regulate protein transcription and translation. Also disclosed are methods of promoting osteogenesis in a patient in need thereof, methods for modulating bone formation and mineralization by implanting in a patient a medical implant comprising ion-exchangeable cations, and methods of regulating BMP gene expression in bone cells in a patient by controlling the delivery of certain cations through ion-exchange via a zeolite incorporated in a bone substitute implanted in a patient so that BMP gene expression can be upregulated or downregulated appropriately.
    Type: Application
    Filed: March 30, 2010
    Publication date: June 7, 2012
    Applicant: DIFUSION TECHNOLOGIES, INC.
    Inventors: Derrick Johns, Matthew Geck, Peter Whang, Jami Hafiz
  • Compositions Having a High Antiviral and Antibacterial Efficacy
    Publication number: 20120141600
    Abstract: Antimicrobial compositions having a rapid antiviral and antibacterial effectiveness, and a persistent antiviral effectiveness, are disclosed. The anti-microbial compositions contain (a) an antimicrobial agent, (b) a disinfecting alcohol, and (c) (i) an organic acid, (ii) an inorganic salt comprising a cation having a valence of 2, 3, or 4 and a counterion capable of lowering a surface pH to about 5 or less, (iii) an aluminum, zirconium, or aluminum-zirconium complex, or (iv) mixtures thereof, wherein the composition has a pH of about 5 or less.
    Type: Application
    Filed: December 18, 2007
    Publication date: June 7, 2012
    Applicant: THE DIAL CORPORATION
    Inventors: Timothy J. Taylor, Priscilla S. Fox, Earl P. Seitz, JR.
  • Material compositions for microbial and chemical protection
    Patent number: 8192765
    Abstract: An antimicrobial and chemical deactivating composition for use in a liquid medium or for incorporation into a coating, structural plastic materials, thin microporous membranes, textiles and sponges. The composition includes macrosize or submicron particles of silver, platinum with silver and their salts with parabens, oxide, salicylate, acetate, citrate, benzoate and phosphate along with copper and zinc salts of the same.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: June 5, 2012
    Assignee: ICET, Inc.
    Inventor: Shantha Sarangapani
  • Nutritional supplement to improve supplementary target protein fraction (TPF) delivery, intracellular absorption and utilization
    Patent number: 8192745
    Abstract: A nutritional supplement includes the primary ingredients: N-acetyl D-glucosamine, cracked cell wall Green Chlorella, Licorice Root Extract, and Potassium Citrate, as well as secondary ingredients: Zinc L-Carnosine, Gamma-Oryzanol and Capsaicin, that improves the bodies uptake, utilization and over-all bioavailability of exogenous target protein fractions (TPF) including but not limited to: glycoproteins, (such as glucosamine) protein isolates as amino acids, glycosaminoglycans (GAG) (including proteoglycans, and mucopolysaccharides), and polysaccharides such as hyaluronic acid (hyaluronan). The biochemical interactions of the composition improves zeta potential for TPF incorporation in the body through direct and indirect interaction with primary cellular and digestive sites of multiple species.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: June 5, 2012
    Inventor: Shawn P. Madere
  • Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles
    Patent number: 8187638
    Abstract: Here we disclose the response of normal human cells to ZnO nanoparticles under different signaling environments and compare it to the response of cancerous cells. ZnO nanoparticles exhibit a strong preferential ability to kill cancerous T cells (˜28-35X) compared to normal cells. Interestingly, the activation state of the cell contributes toward nanoparticle toxicity as resting T cells display a relative resistance while cells stimulated through the T cell receptor and CD28 costimulatory pathway show greater toxicity in direct relation to the level of activation. The novel findings of cell selective toxicity towards potential disease causing cells indicate a potential utility of ZnO nanoparticle in the treatment of cancer and/or autoimmunity.
    Type: Grant
    Filed: September 22, 2008
    Date of Patent: May 29, 2012
    Assignee: Boise State University
    Inventors: Alex Punnoose, Madhusudan R. Kongara, Denise Wingett
  • Organic-Inorganic Composite Particles, Process for Producing the Same, Dispersion Containing the Particles, and Cosmetic Containing the Particles
    Publication number: 20120128748
    Abstract: Organic-inorganic composite particles includes inorganic oxide particles each of which has a cationic charge on the particle surface and polymer gel molecules which are derived from a natural substance, have an anionic functional group and one or more hydroxyl groups in a molecule and have both a shrinking and a swelling property, the polymer gel molecules are electrostatically bonded to surfaces of the inorganic oxide particles; a process for producing the particles; a dispersion containing the particles; and a cosmetic containing the particles. These organic-inorganic composite particles have good dispersibility not only in aqueous solvents such as water but also in non-aqueous solvents and further have characteristics that aggregation of the particles scarcely occurs.
    Type: Application
    Filed: July 30, 2010
    Publication date: May 24, 2012
    Applicant: JGC CATALYSTS AND CHEMICALS LTD.
    Inventors: Kensuke Nagata, Michio Komatsu
  • Metal ion modified high surface area materials for odor removal and control
    Patent number: 8182800
    Abstract: This invention relates to high surface area materials, such as nanoparticles, that are coated with metal ions. These modified nanoparticles have active sites that bind various gases and/or odorous compounds, thereby removing these compounds from a medium such as air or water. Metal ions are adsorbed onto the surface of the nanoparticle and bound strongly to the surface. By selection of the metal ion, specific gaseous compounds and/or odorous compounds can be targeted and removed efficiently and effectively from both aqueous phase and from the air. The modified nanoparticles are useful in numerous article of manufacture for industrial and consumer use.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: May 22, 2012
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventor: John Gavin MacDonald
  • KITS AND METHODS FOR NUTRITION SUPPLEMENTATION
    Publication number: 20120121726
    Abstract: The present invention relates to methods of co-administration of various vitamin and mineral compositions, and in a specific embodiment, said methods comprise co-administering one composition comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states; and kits provided for co-administration of various vitamin and mineral compositions, and in a specific embodiment, said kits comprise one composition comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and a second composition comprising omega-3 fatty acids such as DHA, to supplement the nutritional needs of individuals within physiologically stressful states.
    Type: Application
    Filed: January 23, 2012
    Publication date: May 17, 2012
    Inventors: John A. Giordano, Charles J. Balzer
  • ANTIMICROBIAL SUBSTRATE
    Publication number: 20120114722
    Abstract: A method of preparing antimicrobial-containing polymeric products is provided, the method involving electrospinning a dispersion comprising a dispersible polymer, a fiberizing polymer, and one or more antimicrobial agents. The electrospun material is heated to remove solvent and the fiberizing polymer, giving a nonwoven polymeric material having antimicrobial agent incorporated therein. The material can be in the form of, for example, a non-woven sheet, tube, or covering.
    Type: Application
    Filed: October 13, 2011
    Publication date: May 10, 2012
    Inventors: Robert L. Ballard, Bruce L. Anneaux, Joshua L. Manasco
  • Anti-microbial system for input terminal
    Patent number: 8168119
    Abstract: A method and apparatus disinfecting a computer keyboard includes a metal ion treatment applied to the computer keyboard and other user input devices. A further measure taken is the installation of a shutoff mechanism in the link connecting the computer keyboard to the computer system to open the data connections between the keyboard and host system. Another measure is the periodic and reiterated wipedown of the keyboard and ancillary input devices with an antiseptic wipe. The shutoff mechanism is turned off before the wipedown procedure is carried out, to prevent any incidental keyboard entries made during the wipedown process from being transmitted to the host system.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: May 1, 2012
    Assignee: Key Source International
    Inventors: Philip J. Bruno, Robert A. D. Schwartz
  • Micronized wood preservative formulations comprising boron compounds
    Patent number: 8168304
    Abstract: The present invention provides wood preservative and flame retardant compositions having low leachability comprising micronized boron compounds and, optionally, one or more organic biocides which may be micronized. Also provided is a method for applying the composition to wood and wood products comprising impregnating the wood with the composition.
    Type: Grant
    Filed: January 21, 2010
    Date of Patent: May 1, 2012
    Assignee: Osmose, Inc.
    Inventors: Jun Zhang, Wenjin Zhang, Robert M. Leach
  • LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20120100223
    Abstract: Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area.
    Type: Application
    Filed: December 20, 2011
    Publication date: April 26, 2012
    Applicant: ASHA NUTRITION SCIENCES, INC.
    Inventor: Urvashi BHAGAT
  • HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE SURFACTANTS
    Publication number: 20120100119
    Abstract: Three types of trisiloxane surfactants having the basic formula: MDM? are described wherein the substituents on the differing M and M? groups, in conjunction with pendant polyalkylene oxide substituents on the D group render the surfactant resistant to hydrolysis under either basic or acidic conditions outside the pH range of 6.0 to 7.5. The compositions are useful in agricultural, household and cosmetic applications.
    Type: Application
    Filed: December 8, 2011
    Publication date: April 26, 2012
    Applicant: Momentive Performance Materials Inc.
    Inventors: George A. Policello, Mark D. Leatherman, Wenqing Peng, Suresh K. Rajaraman, Sophia Xia
  • COMBINED USE OF TWO INSECTICIDES
    Publication number: 20120087987
    Abstract: The present disclosure relates to the combined use of two pesticides. A first pesticide composition provides an initial contact kill, and may form a barrier when applied to greasy surfaces. A second pesticide composition provides residual pesticidal activity on the surface. Methods of making and using the pesticide compositions are also provided.
    Type: Application
    Filed: October 12, 2011
    Publication date: April 12, 2012
    Applicant: ECOLAB USA INC.
    Inventors: Victor F. Man, S. John Barcay, Darren M. Jahnke, Yvonne M. Killeen
  • High potency clinical anti-craving treatment and method of use
    Patent number: 8142799
    Abstract: A practical high potency anti-craving medication is disclosed which comprises three components: an amino-acid component, a vitamin component, and a mineral component, wherein each component is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. Additionally, the active agents are received by means of a prolonged administration, preferably by means of an IV drip, thus assuring a period of time in which the active agents are present in desired concentrations, and more preferably a prolonged time during which they are simultaneously present in desired concentrations. The agents of each component are also selected so as to allow easy administration of the medication to patients in three vials of medication rather than as a large number of individual vials.
    Type: Grant
    Filed: August 20, 2005
    Date of Patent: March 27, 2012
    Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore R Keller
  • Oral high potency clinical anti-craving treatment and method of use
    Patent number: 8142800
    Abstract: A practical high potency anti-craving oral medication or combined oral/IV drip medication is disclosed which comprises three components: a group of amino-acid substances, a group of vitamin substances, and a group of minerals, wherein each substance is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. The ingredients of the invention are selected to cooperate in easing metabolization in the bodies of individuals suffering the various medical conditions associated with substance abuse. The ingredients are provided orally to ease administration and to provide convenient use by patients: the oral medication may be a maintenance dosage or a corrective dosage.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: March 27, 2012
    Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore Keller
  • Hydrolysis Resistant Organomodified Trisiloxane Surfactants
    Publication number: 20120064052
    Abstract: Three types of trisiloxane surfactants having the basic formula: MDM? are described wherein the substituents on the differing M and M? groups, in conjunction with pendant polyalkylene oxide substituents on the D group render the surfactant resistant to hydrolysis under either basic or acidic conditions outside the pH range of 6.0 to 7.5. The compositions are useful in agricultural, household and cosmetic applications.
    Type: Application
    Filed: June 22, 2011
    Publication date: March 15, 2012
    Applicant: Momentive Performance Materials Inc.
    Inventors: George A. Policello, Mark D. Leatherman, Wenqing Peng, Suresh K. Rajaraman, Sophia Xia
  • BIOCIDAL COMPOSITION
    Publication number: 20120064138
    Abstract: The present invention relates to a biocidal composition comprising an inorganic compound and a polymer where the inorganic compound has been prepared using a controlled precipitation technique. The biocidal compositions overcome the settling and agglomeration problems of conventional inorganic biocidal compositions and offer enhanced activity, consistency, and stable long term release of the active species. The invention also relates to a method of preparation of the compositions and to their use as a biocidal composition and in making or coating articles comprising it.
    Type: Application
    Filed: April 28, 2009
    Publication date: March 15, 2012
    Applicant: HARMAN TECHNOLOGY LIMITED
    Inventors: David Beveridge, Stephen Critchley, Karen Nicola Harvey, Jeffrey Ronald King, Kenneth Miller McCombe, Martyn Howard Pendlebury
  • METHOD FOR STIMULATING HAIR GROWTH
    Publication number: 20120064174
    Abstract: The present teachings provide methods for stimulating the hair growth on a human head including simultaneous administration: a) by oral or transdermal route of a composition containing a 5-alpha-reductase inhibitor or a peripheral vasodilator, and b) by topical route of a composition containing as active ingredient an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species or an extract of Salix species and zinc sulfate.
    Type: Application
    Filed: August 2, 2011
    Publication date: March 15, 2012
    Applicant: LEGACY HEALTHCARE HOLDING LTD.
    Inventors: Saad Harti, André Ulmann
  • Compositions and Methods for Targeted Thermomodulation
    Publication number: 20120059307
    Abstract: Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.
    Type: Application
    Filed: August 26, 2011
    Publication date: March 8, 2012
    Applicant: SIENNA LABS, INC.
    Inventors: Todd James Harris, Alice Ann Chen
  • Polymeric pharmaceutical agent for treatment of cancer and method for production of the same
    Patent number: 8128959
    Abstract: The present invention provides a polymeric agent which can incorporate a large amount of a drug, accumulate selectively in a tumor site, and has a molecular size of more than that for renal excretion. A metalloporphyrin derivative (such as zinc protoporphyrin) is associated with a styrene-maleic acid copolymer via non-covalent bond to give a SMA micelle complex, allowing provision of a polymeric pharmaceutical agent for treatment of cancer with a large amount of the drug incorporated. The SMA micelle complex can be produced by a method, wherein the metalloporphyrin derivative reacts with the styrene-maleic acid copolymer in the absence of a condensation agent under an alkaline condition, solubilized, adjusted to have a pH of 6-8, and subjected to a procedure for separating a polymer component to recover the micelle complex component for the polymeric pharmaceutical agent.
    Type: Grant
    Filed: April 13, 2006
    Date of Patent: March 6, 2012
    Assignee: Hiroshi Maeda
    Inventors: Hiroshi Maeda, Khaled Greish
  • Intrauterine contraceptive device
    Patent number: 8118028
    Abstract: An intrauterine contraceptive device comprising a carrier body (1) and an active metallic alloy (4), characterized in that the active metallic alloy is of the formula ZnxCuyMnzAuk (I) or ZnxCuyMnzAgk (II), wherein x+y+z+k=100 weight %, x is in the range from approximately 18 to 30 weight %, z is in the range from approximately 0.5 to 3 weight %, and k is in the range from approximately 3 to 12 weight %, y being the balance.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: February 21, 2012
    Inventor: Melinda-Kinga Karpati
  • Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
    Patent number: 8119168
    Abstract: Disclosed are compositions comprising an effective amount of a zinc containing material having an aqueous solubility within the composition of less than about 25% by weight at 25° C.; from about 5% to about 50% of a surfactant; and from about 40% to about 95% water; wherein the pH of the composition is greater than about 7. Further disclosed are compositions comprising an effective amount of a zinc containing material having an aqueous solubility within the composition of less than about 25% by weight at 25° C.; from about 5% to about 50% of a surfactant; and from about 0.1% to about 5% of a zinc ionophoric material; from about 40% to about 95% water; and wherein the pH of the composition is greater than about 7.
    Type: Grant
    Filed: March 18, 2003
    Date of Patent: February 21, 2012
    Assignee: The Procter & Gamble Company
    Inventors: Eric Scott Johnson, Elizabeth Ann Crane, James Robert Schwartz, Carl Hinz Margraf, III, Gregory V. Tormos, David Thomas Warnke
  • Ingestible Supplement for Women
    Publication number: 20120040018
    Abstract: An ingestible nutritional substance (supplement and the like) including vitamins, minerals and other ingredients beneficial to a woman and/or her child that a woman may take at a time of her life surrounding pregnancy. This includes by ingesting determined and suited types and amounts of ingredients, including at selected times, to best assist the woman and/or infant's needs at the respective times. The ingestible supplement can be formulated for drinking with appropriate nutritional and health benefits as well as with desired lifestyle and taste and aesthetic attributes. The dosing and packaging of the supplement to best suit a specific class of woman's and baby's needs are also described. Other aspects are directed to the preservation, storage and dispensation of one or more ingredients that may not be stable with one another during storage.
    Type: Application
    Filed: August 10, 2011
    Publication date: February 16, 2012
    Inventors: Jonathan S. Thierman, Ibrahim M. Hallaj
  • ANTIBACTERIAL COMPOSITION COMPRISING 4-ISOPROPYL-3-METHYLPHENOL AND ZINC IONS
    Publication number: 20120039820
    Abstract: A composition such as an oral care composition comprising an antibacterial system comprising 4-isopropyl-3-methyl phenol (IPMP), a source of zinc ions and an anionic surface active agent is described.
    Type: Application
    Filed: April 1, 2010
    Publication date: February 16, 2012
    Applicant: Glaxo Group Limited
    Inventors: Alison Axe, David Bradshaw
  • Pharmaceutical compositions for the administration of aptamers
    Patent number: 8114440
    Abstract: Pharmaceutical compositions comprising an aptamer and an amino acid ester or amide or an aptamer; a divalent metal cation; and a carboxylic acid, a phospholipid, a phosphatidyl choline, or a sphingomyelin. Methods of treating or preventing a condition in an animal comprising administering to the animal the pharmaceutical compositions.
    Type: Grant
    Filed: April 10, 2006
    Date of Patent: February 14, 2012
    Assignee: Idexx Laboratories Inc.
    Inventor: Yerramilli V. S. N. Murthy
  • 4-ISOPROPYL-3-METHYLPHENOL FOR THE TREATMENT OF INFLAMMATION
    Publication number: 20120034312
    Abstract: This invention relates to the use of 4-isopropyl-3-methylphenol (IPMP) for combating inflammation and compositions comprising IPMP for such use.
    Type: Application
    Filed: April 1, 2010
    Publication date: February 9, 2012
    Inventor: Jingjun Yang
  • COMPOSITION FOR REGULATING LIPID METABOLISM
    Publication number: 20120034201
    Abstract: This invention concerns a nutraceutical and/or food composition for regulating, among other things, lipid metabolism in humans and animals, and methods of use of said nutraceutical and/or food composition.
    Type: Application
    Filed: April 15, 2010
    Publication date: February 9, 2012
    Applicant: ACTIGENOMICS S.A.
    Inventors: Walter Wahli, Marie Françoise Yvonne Bourgeois-Lugand, Bernadette Husson-Robert, Gilles Didier Parisot
  • ANTI-MICROBIAL APPLICATIONS FOR ACIDIC COMPOSITION OF MATTER
    Publication number: 20120027869
    Abstract: Methods of using a non-irritant, low pH acidic composition to destroy undesirable microorganisms are described. The methods may be used on food products, food processing equipment, and in aqueous solutions.
    Type: Application
    Filed: July 14, 2011
    Publication date: February 2, 2012
    Inventors: Barry Cummins, David Creasey